Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biovie Inc (BIVI)

Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting GlobeNewswire - Tue Apr 14, 7:00AM CDT

CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5600 (+6.85%)
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference ACCESS Newswire - Thu Apr 2, 3:45AM CDT

ORLANDO, FL / ACCESS Newswire / April 2, 2026 / RedChip Companies, an industry leader in investor relations, media, and research for microcap and small-cap companies, today announced its upcoming virtual...

NXL : 0.4633 (-0.26%)
BIVI : 1.5600 (+6.85%)
SXTP : 1.7800 (+2.89%)
BFRG : 0.9943 (-7.94%)
LTRN : 2.49 (-1.97%)
BioVie Announces Abstract Accepted for Presentation at AD/PD 2026 GlobeNewswire - Thu Mar 12, 7:00AM CDT

CARSON CITY, Nev., March 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5600 (+6.85%)
60 Degrees Pharmaceuticals and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire - Fri Feb 27, 3:00AM CST

ORLANDO, FL / ACCESS Newswire / February 27, 2026 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) and BioVie, Inc. (NASDAQ:BIVI) on the RedChip Small Stocks,...

BIVI : 1.5600 (+6.85%)
SXTP : 1.7800 (+2.89%)
Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on March 4 GlobeNewswire - Mon Feb 23, 7:00AM CST

CARSON CITY, Nev., Feb. 23, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5600 (+6.85%)
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America ACCESS Newswire - Sat Feb 21, 4:45AM CST

Commercial Sponsors

SNYR : 0.5246 (+3.49%)
PETV : 0.7990 (unch)
NTHI : 5.34 (+6.37%)
BIVI : 1.5600 (+6.85%)
VTIX : 6.17 (+1.31%)
YYGH : 1.6100 (+5.92%)
SGTM : 0.2599 (+1.92%)
VVOS : 0.9741 (-10.63%)
BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting GlobeNewswire - Thu Feb 12, 7:00AM CST

CARSON CITY, Nev., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 1.5600 (+6.85%)
New to The Street Broadcasts Show #716 Tonight at 6:30 PM ET on Bloomberg Television Featuring Stardust Power (NASDAQ:SDST), BioVie (NASDAQ:BIVI), Roadzen (NASDAQ:RDZN), with Special Segments from Kelsey Grammer on KAREN and Andrew Shaw of 250DAYS.ORG ACCESS Newswire - Sat Jan 17, 8:45AM CST

The show airs as sponsored programming with national television commercials from Synergy CHC, NeOnc Technologies, The Sustainable Green Team (SGTM), Roadzen, and Aeries Technology (AERT)

RDZN : 1.2000 (+1.69%)
SDST : 2.95 (+1.72%)
BIVI : 1.5600 (+6.85%)
BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease GlobeNewswire - Thu Jan 8, 7:00AM CST

- Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone - - Topline Results from the SUNRISE-PD Trial Expected in 1H 2026...

BIVI : 1.5600 (+6.85%)
HALPER SADEH LLC ENCOURAGES BIOVIE INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS PR Newswire - Wed Dec 24, 2025

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

BIVI : 1.5600 (+6.85%)

Barchart Exclusives

As NetApp Expands Its Relationship With Google Cloud, Should You Buy, Sell, or Hold NTAP Stock? Barchart - 1 hour ago
Does this AI-driven push by NetApp make the stock a buy now, or start thinking about taking profits? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.